<DOC>
	<DOCNO>NCT01063387</DOCNO>
	<brief_summary>This study open-label , randomize study , design investigate efficacy Extended-field irradiation ( EFI ) reduce recurrence para-aortic lymph node ( PAN ) supraclavicular lymph node , also improve disease-free survival locally advanced uterine cervical cancer . This study include translational research component primary tumor lymph node stain Sema4c , randomization . According investigator study result , patient pelvic lymph node metastasis likely develop distant metastasis include recurrence PAN supraclavicular lymph node . Primary cervical cancer tissue lymph node examine expression Sema4c registration , patient randomize arm ( pelvis vs. EFI ) . The investigator expect high benefit EFI patient Sema4c-positive lymph node .</brief_summary>
	<brief_title>Prophylactic Irradiation Para-Aortic Lymph Nodes Supraclavicular Lymph Nodes Locally Advanced Uterine Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Patients ( adequately clinically stag ) primary , untreated , histologically confirm invasive squamous cell carcinoma , adenocarcinoma , adenosquamous carcinoma uterine cervix , FIGO stage IB1 pelvic lymph node metastasis , IB2 , IIA ( ≥4cm tumor size , pelvic LN metastasis ) , IIB , IIIA , IIIB ? unilateral pelvic wall extension Patients negative , paraaortic lymphadenopathy determine pelvic MRI and/or PET/CT scan . Patients adequate bone marrow function : ANC great equal 1,500/ul , platelet great equal 100,000/ul beginning . Patients adequate renal function : creatinine equal less 2.0 mg/dL . Patients sign approve informed consent authorization Patients ECOG Performance Status 0 , 1 , 2 Karnofsky Performance Scale 100 , 90 , 80 , 70 , 60 , 50 Age : 18≤age≤80 Stage IIIb bilateral pelvic wall extension stage IVB lesion eligible . Patients histology squamous , adeno , adenosquamous cell carcinoma Patients receive prior radiotherapy pelvis total hysterectomy Patients diagnosis malignant tumor nonmalignant melanoma skin cancer stage I. II papillary , follicular thyroid cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>cervical cancer , semaphorin 4C ( Sema4C ) ,</keyword>
	<keyword>Prophylactic Irradiation</keyword>
</DOC>